Position in RCUS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,418,122
+$2,444,610 QoQ
Shares Held
110,870
+146.0% QoQ
Ownership
0.087%
of shares outstanding
% of Portfolio
2.39%
of 13F equity value
Holder Rank
#67
of 230 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 36%
Shared 0%
None 64%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $69,797,747 across 47 Biotechnology names. RCUS ranks #5 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $11,925,150 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
41,987 | $3,995,902 | |
| 3 | BNTX |
BioNTech SE
|
41,869 | $3,895,910 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
78,310 | $3,683,702 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
This page
|
110,870 | $3,418,122 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
220,180 | $3,208,022 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
|
79,043 | $2,745,953 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,432 | $2,698,237 |
All Filings in RCUS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,418,122 | 110,870 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $973,512 | 45,070 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,356,999 | 56,945 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,005,752 | 368,070 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,094,177 | 257,270 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $210,929 | 26,870 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,035,629 | 69,552 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,154,731 | 75,522 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,193,803 | 78,385 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,767,828 | 93,635 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,861,008 | 97,435 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,739,435 | 375,456 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,199,691 | 354,490 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $5,356,103 | 293,646 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $4,931,807 | 238,482 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,939,157 | 227,032 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $7,900,555 | 311,782 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,682,428 | 338,480 | Shares | Sole | 2022-05-10 | |
| 2021-12-31 | $11,461,508 | 283,210 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $25,769,278 | 739,010 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $18,515,179 | 674,260 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,126,616 | 859,210 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $22,355,713 | 861,160 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $15,816,792 | 922,800 | Shares | Sole | 2020-11-13 | |
| 2020-03-31 | $3,625,636 | 261,213 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||